Publications

5808 Results

Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group Study

Authors
JH Doroshow;S McCoy;JS Macdonald;BF Issell;T Patel;PW Cobb;KJ Yost;JL Abrruzzese
Journal / Conference
Investigational New Drugs 24:537-542
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S9915

Randomized trial of adjuvant intraperitoneal alpha-interferon in Stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemotherapy: An intergroup study

Authors
DS Alberts;EV Hannigan;PY Liu;C Jiang;S Wilczynski;L Copeland;M Markman
Journal / Conference
Gynecologic Oncology 100:133-138
Year
2006
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8790 (INT-0083) (GOG-133)

A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group Study 0007

Authors
FP Worden;J Moon;W Samlowski;JI Clark;SR Dakhil;S Williamson;SG Urba;J Ensley;MH Hussain
Journal / Conference
Cancer 107(2):319-327
Year
2006
Research Committee(s)
Head and Neck
Study Number(s)
S0007

A phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study

Authors
RP Whitehead;S McCoy;SE Rivkin;HM Gross;ME Conrad;GC Doolittle;RA Wolff;JW Goodwin;SR Dakhil;JL Abbruzzese
Journal / Conference
Investigational New Drugs 24:515-520
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S0107

Phase II trial of R115777 (NSC #70818) in patients with advanced colorectal cancer: a Southwest Oncology Group study

Authors
RP Whitehead;S McCoy;J Macdonald;SE Rivkin;MA Neubauer;SR Dakhil;HJ Lenz;MS Tanaka Jr;JL Abbruzzese
Journal / Conference
Investigational New Drugs 24:335-341
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S9923

Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma

Authors
G Von Burton;C Rankin;MM Zalupski;GM Mills;EC Borden;K Antman
Journal / Conference
American Journal of Clinical Oncology 29(1):59-61
Year
2006
Research Committee(s)
Sarcoma
Study Number(s)
S9802

Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer. A Southwest Oncolgy Group (SWOG) Trial.

Authors
SK Williamson;S McCoy;DR Gandara;SR Dakhil;KJ Yost;JC Paradelo;JN Atkins;CD Blanke;JL Abbruzzese
Journal / Conference
American Journal of Clinical Oncology 29(2):116-122, 2006.
Year
2006
Research Committee(s)
Gastrointestinal
Study Number(s)
S0101

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16

Authors
D Petrylak;D Pauler Ankerst;CS Jiang;CM Tangen;MHA Hussain;PN Lara;JA Jones;ME Taplin;PA Burch;M Kohli;MC Benson;EJ Small;D Raghavan;ED Crawford
Journal / Conference
Journal of the National Cancer Institute 98(8):516-521
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials

Authors
JM Unger;CA Coltman Jr;JJ Crowley;L Hutchins;S Martino;R Livingston;J Macdonald;C Blanke;D Gandara;ED Crawford;KS Albain
Journal / Conference
Journal of Clinical Oncology 24(1):141-144
Year
2006

The prostate cancer prevention trial: design, biases, and interpretation of study results

Authors
PJ Goodman;IM Thompson Jr;CM Tangen;JJ Crowley;LG Ford;CA Coltman Jr
Journal / Conference
Journal of Urology 175:2234-2242
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217